NLS Pharmaceutics (NLS Pharmaceutics) Market Cap : $6.47 Mil (As of May. 17, 2024)

View and export this data going back to 2021. Start your Free Trial

What is NLS Pharmaceutics Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). NLS Pharmaceutics's share price for the quarter that ended in Jun. 2023 was $1.1. NLS Pharmaceutics's Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 32.43 Mil. Therefore, NLS Pharmaceutics's market cap for the quarter that ended in Jun. 2023 was $35.67 Mil.

NLS Pharmaceutics's quarterly market cap increased from Jun. 2022 ($10.44 Mil) to Dec. 2022 ($41.83 Mil) but then declined from Dec. 2022 ($41.83 Mil) to Jun. 2023 ($35.67 Mil).

NLS Pharmaceutics's annual market cap increased from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($18.01 Mil) and increased from Dec. 2021 ($18.01 Mil) to Dec. 2022 ($41.83 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. NLS Pharmaceutics's Enterprise Value for Today is $5.33 Mil.

NLS Pharmaceutics Market Cap Historical Data

The historical data trend for NLS Pharmaceutics's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NLS Pharmaceutics Market Cap Chart

NLS Pharmaceutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Market Cap

Get a 7-Day Free Trial

18.01

41.83

NLS Pharmaceutics Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Market Cap	Get a 7-Day Free Trial							37.89	18.01	10.44	41.83	35.67

Competitive Comparison of NLS Pharmaceutics's Market Cap

For the Biotechnology subindustry, NLS Pharmaceutics's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NLS Pharmaceutics's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NLS Pharmaceutics's Market Cap distribution charts can be found below:

* The bar in red indicates where NLS Pharmaceutics's Market Cap falls into.

NLS Pharmaceutics Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

NLS Pharmaceutics's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$1.29	*	32.4289
	=	$41.83

NLS Pharmaceutics's Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	$1.1	*	32.4289
	=	$35.67

NLS Pharmaceutics (NAS:NLSP) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

NLS Pharmaceutics Market Cap Related Terms

Thank you for viewing the detailed overview of NLS Pharmaceutics's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

NLS Pharmaceutics (NLS Pharmaceutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

The Circle 6, Zurich, CHE, 8058

Website

https://www.nlspharma.com

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.